(19)

(11)

EP 4 504 765 A1

(12)

(43) Date of publication: 12.02.2025 Bulletin 2025/07 (21) Application number: 23717812.4 (22) Date of filing: 03.04.2023

(51) International Patent Classification (IPC):  C07K 14/605(2006.01) C07K 1/02(2006.01) C07K 5/103(2006.01) C07K 5/113(2006.01) A61K 47/54(2017.01) C07K 5/097(2006.01) C07K 5/107(2006.01) C07K 5/117(2006.01) (52) Cooperative Patent Classification (CPC): C07K 14/605; A61K 47/542; C07K 5/1024; C07K 5/1021; C07K 5/1016; C07K 14/001 (86) International application number: PCT/US2023/065258 (87) International publication number: WO 2023/196765 (12.10.2023 Gazette 2023/41)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 04.04.2022 US 202263327120 P (71) Applicant: Eli Lilly and Company Indianapolis, IN 46285 (US)	(72) Inventors: KOPACH, Michael Eugene Indianapolis, Indiana 46206-6288 (US) MURZINSKI, Emily Suzanne Indianapolis, Indiana 46206-6288 (US) (74) Representative: Eli Lilly and Company Limited  8 Arlington Square West Downshire Way Bracknell Berkshire RG12 1PU Bracknell Berkshire RG12 1PU (GB)